Skip to main content
. Author manuscript; available in PMC: 2013 May 6.
Published in final edited form as: Circ Cardiovasc Qual Outcomes. 2010 Jun 15;3(4):366–373. doi: 10.1161/CIRCOUTCOMES.109.905810

Table 2. Associations Between the Mediterranean Diet Score and Heart Rate Variability in the Entire Sample.

Outcome Difference (%) (95% CI)per 1-unit increment in score*(n = 276) P value Means (95% CI) of Log-Transformed HRV Measures P value§

Diet Score = 0-3 (n =78) Diet Score = 4 (n =58) Diet Score = 5 (n =65) Diet Score = 6-9 (n =75)
Time-domain
Model 1: Zygosity and nutritional factors not in the score adjusted
SDNN, ms 1.8 (0.2, 3.4) 0.03 4.77 (4.71, 4.82) 4.88 (4.81, 4.94) 4.85 (4.79, 4.91) 4.87 (4.81, 4.93) 0.02
SDANN, ms 1.6 (−0.1, 3.3) 0.07 4.60 (4.54, 4.66) 4.69 (4.63, 4.76) 4.66 (4.60, 4.73) 4.69 (4.63, 4.75) 0.04
SDNNI, ms 2.9 (1.2, 4.8) 0.001 3.98 (3.91, 4.04) 4.10 (4.03, 4.17) 4.13 (4.06, 4.19) 4.13 (4.06, 4.19) 0.003
rMSSD, ms 3.9 (1.3, 6.5) 0.003 3.37 (3.28, 3.45) 3.58 (3.48, 3.67) 3.55 (3.46, 3.64) 3.55 (3.46, 3.64) 0.005
pNN50, % 10.5 (3.6, 18) 0.003 1.49 (1.27, 1.72) 1.90 (1.66, 2.15) 1.87 (1.63, 2.11) 1.96 (1.74, 2.18) 0.005
Model 2: Multivariate adjusted
SDNN, ms 1.7 (0.1, 3.4) 0.04 4.73 (4.63, 4.84) 4.84 (4.74, 4.95) 4.80 (4.70, 4.90) 4.83 (4.73, 4.93) 0.02
SDANN, ms 1.6 (−0.1, 3.4) 0.07 4.55 (4.44, 4.67) 4.65 (4.54, 4.77) 4.61 (4.50, 4.72) 4.65 (4.54, 4.75) 0.03
SDNNI, ms 2.7 (1, 4.5) 0.003 3.98 (3.87, 4.09) 4.10 (3.99, 4.21) 4.08 (3.98, 4.19) 4.11 (4.01, 4.22) 0.006
rMSSD, ms 3.8 (1.1, 6.4) 0.005 3.42 (3.26, 3.58) 3.60 (3.43, 3.76) 3.57 (3.42, 3.73) 3.59 (3.44, 3.75) 0.007
pNN50, % 10.1 (3.2, 17.4) 0.004 1.73 (1.32, 2.14) 2.08 (1.66, 2.50) 2.01 (1.61, 2.41) 2.18 (1.78, 2.57) 0.007
Frequency-domain
Model 1: Zygosity and nutritional factors not in the score adjusted
TotPow, ms2 4.5 (1.1, 7.9) 0.009 9.29 (9.17, 9.41) 9.54 (9.41, 9.67) 9.51 (9.39, 9.63) 9.53 (9.42, 9.65) 0.003
ULF, ms2 4.1 (0.4, 7.9) 0.03 9.00 (8.87, 9.12) 9.24 (9.10, 9.38) 9.18 (9.05, 9.31) 9.23 (9.10, 9.35) 0.01
VLF, ms2 5.5 (1.8, 9.5) 0.004 7.41 (7.28, 7.54) 7.65 (7.51, 7.79) 7.72 (7.58, 7.85) 7.67 (7.54, 7.80) 0.01
LF, ms2 7.9 (2.8, 13.3) 0.002 6.40 (6.23, 6.57) 6.65 (6.47, 6.84) 6.80 (6.62, 6.98) 6.74 (6.57, 6.91) 0.02
HF, ms2 4.5 (−1.2, 10.6) 0.12 5.12 (4.93, 5.31) 5.60 (5.39, 5.81) 5.43 (5.23, 5.63) 5.40 (5.21, 5.59) 0.10
Model 2: Multivariate adjusted
TotPow, ms2 3.6 (0.2, 7.1) 0.04 9.26 (9.05, 9.48) 9.50 (9.29, 9.72) 9.42 (9.22, 9.63) 9.47 (9.27, 9.67) 0.007
ULF, ms2 3.0 (−0.6, 7.0) 0.10 8.98 (8.74, 9.21) 9.21 (8.97, 9.45) 9.11 (8.88, 9.33) 9.17 (8.95, 9.39) 0.02
VLF, ms2 4.8 (1.0, 8.7) 0.012 7.45 (7.22, 7.68) 7.69 (7.46, 7.93) 7.68 (7.46, 7.90) 7.68 (7.47, 7.90) 0.02
LF, ms2 7.7 (2.6, 13.1) 0.003 6.35 (6.04, 6.66) 6.56 (6.25, 6.87) 6.66 (6.36, 6.95) 6.66 (6.37, 6.95) 0.01
HF, ms2 4.7 (−1.0, 10.8) 0.11 5.12 (4.77, 5.47) 5.59 (5.23, 5.95) 5.40 (5.07, 5.74) 5.43 (5.11, 5.76) 0.07
*

Values are % differences in geometric means (95% CI) calculated from the β coefficient of the diet score.

Total energy intake (continuous), egg consumption (continuous), potato consumption (continuous).

Demographic factors [education (continuous) and marital status (yes/no)]; lifestyle factors [physical activity (continuous), waist-to-hip ratio (continuous)]; coronary risk factors [Framingham risk score (continuous) and plasma triglycerides (continuous)]; use of fish oil supplements (yes/no), β-blockers (yes/no), and other medications (statins, aspirin antihypertensives, and antihyperglycemics) (yes/no).

§

Test for trend across diet groups.